These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18540789)

  • 1. Transitioning and adjusting insulin analog therapy in elderly patients.
    Bray B
    Consult Pharm; 2008 Apr; 23 Suppl B():17-23. PubMed ID: 18540789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When oral agents fail: optimizing insulin therapy in the older adult.
    Meece J
    Consult Pharm; 2009 Jun; 24 Suppl B():11-7. PubMed ID: 19555131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimizing the risk of hypoglycemia in older adults: a focus on long-term care.
    Garza H
    Consult Pharm; 2009 Jun; 24 Suppl B():18-24. PubMed ID: 19555132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Making the transition from oral to insulin therapy.
    Riddle MC
    Am J Med; 2005 May; 118 Suppl 5A():14S-20S. PubMed ID: 15850549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transition from insulin infusions to long-term diabetes therapy: the argument for insulin analogs.
    Braithwaite SS
    Semin Thorac Cardiovasc Surg; 2006; 18(4):366-78. PubMed ID: 17395034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin therapy in the elderly patient with diabetes.
    Tanwani LK
    Am J Geriatr Pharmacother; 2011 Feb; 9(1):24-36. PubMed ID: 21459306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
    Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologic insulin replacement in type 2 diabetes: optimizing postprandial glucose control.
    Robertson C
    Diabetes Educ; 2006; 32(3):423-32. PubMed ID: 16772658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstrating strategies for initiation of insulin therapy: matching the right insulin to the right patient.
    Meneghini L
    Int J Clin Pract; 2008 Aug; 62(8):1255-64. PubMed ID: 18705822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative hypoglycemia in a patient receiving insulin detemir.
    Olson RP; Bethel MA; Lien L
    Anesth Analg; 2009 Jun; 108(6):1836-8. PubMed ID: 19448209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemic control in hospitalized patients not in intensive care: beyond sliding-scale insulin.
    Nau KC; Lorenzetti RC; Cucuzzella M; Devine T; Kline J
    Am Fam Physician; 2010 May; 81(9):1130-5. PubMed ID: 20433129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suggested insulin regimens for patients with type 1 diabetes mellitus who wish to fast during the month of Ramadan.
    Kobeissy A; Zantout MS; Azar ST
    Clin Ther; 2008 Aug; 30(8):1408-15. PubMed ID: 18803984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoglycemia in type 2 diabetes.
    Banarer S; Cryer PE
    Med Clin North Am; 2004 Jul; 88(4):1107-16, xii-xiii. PubMed ID: 15308392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recommendations concerning the initial regimen and dose adjustments of insulin therapy for type 2 diabetes mellitus].
    Houweling ST; Timmerman GJ; Hoogstraten MF; Ubink-Veltmaat LJ; Verhoeven S; Bilo HJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1823-7. PubMed ID: 12382366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin glargine: cornerstone treatment for type 2 diabetes patients. Introduction.
    Garg SK
    Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():1-4. PubMed ID: 18577151
    [No Abstract]   [Full Text] [Related]  

  • 16. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin therapy in elderly patients with type 2 diabetes: the role of insulin glargine.
    Janka HU
    Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():35-41. PubMed ID: 18577155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.
    Bakiner O; Ertorer ME; Bozkirli E; Tutuncu NB; Demirag NG
    Acta Diabetol; 2009 Mar; 46(1):63-5. PubMed ID: 18825302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 1 diabetes mellitus: effective insulin strategies with less hypoglycemia.
    Bolli GB
    Postgrad Med; 2004 Nov; 116(5 Suppl Exploring):13-20. PubMed ID: 19667675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
    Massi-Benedetti M; Orsini-Federici M
    Diabetes Care; 2008 Feb; 31 Suppl 2():S131-5. PubMed ID: 18227473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.